Tag Archive for: Mindset Pharma
https://psychedelicspotlight.com/wp-content/uploads/2022/12/YT-Cover.png 3000 5334 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2022-12-22 16:37:562022-12-22 16:37:56Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James LanthierPodcasts
In this conversation, David and James discuss the great deal of work that Mindset has done to set the stage for the launch of one or more drug candidates into first in-human clinical trials in 2023.
https://psychedelicspotlight.com/wp-content/uploads/2022/06/Psychedelic_business_news_June_17.png 800 1200 James Hallifax https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png James Hallifax2022-06-17 15:52:182022-06-17 21:59:31Psychedelic Business Spotlight – June 17
Psychedelic Business Spotlight – June 17Business, News, Stock Reports
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
https://psychedelicspotlight.com/wp-content/uploads/2022/04/Psychedelic_Business_Spotlight_mindset_pharma_psyence_filament_health_nue_life_ehave_wellbeing_digital_sciences_psychedelic_spotlight.jpg 800 1200 Greg Gilman https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Greg Gilman2022-04-22 18:13:192022-06-07 23:01:16Psychedelic Business Spotlight – April 22
Psychedelic Business Spotlight – April 22Business, Stock Reports
This week in psychedelic business news: Mindset Pharma files a new patent; Ehave's MetaHealthU app seeks to cure HPPD; Wellbeing Digital Sciences contemplates a sale.
https://psychedelicspotlight.com/wp-content/uploads/2022/02/Psychedelic_Business_Spotlight_February_4_Wesana_Health_Mike_Tyson_Levitee_Labs_Numinus_Wellness_Mindset_Pharma_MindMed.jpg 962 1920 Greg Gilman https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Greg Gilman2022-02-04 18:54:442022-06-07 23:16:11Psychedelic Business Spotlight – February 4
Psychedelic Business Spotlight – February 4Business, Stock Reports
Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness company, has appointed Philip van den Berg as…
https://psychedelicspotlight.com/wp-content/uploads/2022/01/Why_Mindset_Pharma_Deal_with_Big_Pharma_Is_Big_Deal_for_Psychedelics_Psychedelic_Spotlight.jpg 875 1310 PSYCSpotlight Sponsored Content https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png PSYCSpotlight Sponsored Content2022-01-31 18:29:312022-01-31 18:29:33Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics
Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for PsychedelicsBusiness
The partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader in the industry.
https://psychedelicspotlight.com/wp-content/uploads/2022/01/Psychedelic_Business_Spotlight_Mindset_Pharma_Atai_Life_Sciences_Lophos_Pharma_Nova_Mentis_Mydecine_Ketamine_One.jpg 962 1920 Greg Gilman https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Greg Gilman2022-01-28 18:26:022022-06-07 23:16:25Psychedelic Business Spotlight — January 28
Psychedelic Business Spotlight — January 28Business, Stock Reports
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.
https://psychedelicspotlight.com/wp-content/uploads/2022/01/Psychedelic_Spotlight_Mindset_Pharma.png 855 1200 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2022-01-07 22:42:272022-06-08 13:48:13Interview with James Lanthier, CEO of Mindset Pharma
Interview with James Lanthier, CEO of Mindset PharmaInterviews, Podcasts
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are creating. He also discusses some big breaking news!
https://psychedelicspotlight.com/wp-content/uploads/2022/01/Psychedelic_Business_Spotlight_Mindset_Pharma_Awakn_Life_Sciences_Levitee_Labs_Field_Trip_Health_Psychedelic_Spotlight.jpg 962 1920 Travis Reilly https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Travis Reilly2022-01-07 18:17:452022-06-07 23:16:55Psychedelic Business Spotlight — January 7
Psychedelic Business Spotlight — January 7Business, Stock Reports
This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures buys virtual land for psychedelic therapy.
https://psychedelicspotlight.com/wp-content/uploads/2022/01/Mindset_Pharma_The_McQuade_Center_Partner_Develop_Novel_Psychedelic_Compounds_Psychedelic_Spotlight.jpg 875 1310 Greg Gilman https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Greg Gilman2022-01-05 17:01:112022-01-07 17:50:30Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds
Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic CompoundsBusiness
It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.
https://psychedelicspotlight.com/wp-content/uploads/2021/12/Psychedelic_Business_Spotlight_December_31_Mindset_Pharma_Core_One_Laboratories_Psychedelic_Spotlight.jpg 962 1920 Greg Gilman https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Greg Gilman2021-12-31 18:22:552022-06-07 23:17:01Psychedelic Business Spotlight – December 31
Psychedelic Business Spotlight – December 31Business, Stock Reports
This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect microdosing drug profile," and Core One Labs is preparing to capitalize on functional mushroom market.